Kyn is an oncometabolite that activates the aryl hydrocarbon receptor, a transcription factor that regulates progrowth genes, and Kyn also inhibits T-cell activity, which promotes cancer cell immune evasion [22]. The gene discussed is AHR; the disease is cancer.